Value and Risk of Class I and III Antiarrhythmic Drugs.
Saved in:
| Title: | Value and Risk of Class I and III Antiarrhythmic Drugs. |
|---|---|
| Authors: | Burkart, Felix1 |
| Source: | Pacing & Clinical Electrophysiology. Mar1994, Vol. 17 Issue 3, p467-472. 6p. |
| Subjects: | Myocardial depressants, Arrhythmia treatment, Phenytoin, Mexiletine, Quinidine, Amiodarone, Cardiovascular agents |
| Abstract: | Discusses the value and risk of class one and three antiarrhythmic drugs. Phenytoin; Mexiletine; Aprindine; Encainide; Quinidine; Amiodarone; Prospective randomized clinical trial in patients at risk after myocardial infarction where physicians to avoid the pitfalls of previous antiarrhythmic trials. |
| Database: | Engineering Source |
Be the first to leave a comment!
